Vir Biotechnology (VIR) PT Raised to $200 at H.C. Wainwright
H.C. Wainwright analyst Patrick Trucchio raised the price target on Vir Biotechnology (NASDAQ: VIR) to $200.00 (from $135.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)